Amarin | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amarin USD 531.38M 20.5M 2024-09
AstraZeneca USD 41.04B 168M 2025-03
DBV Technologies USD 27.4M 26.63M 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Novartis USD 44.05B 605M 2024-12



Amarin Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.